Search results for "70"

showing 10 items of 9933 documents

Effects of time of day on resistance exercise-induced anabolic signaling in skeletal muscle

2013

This study examined the effect of morning versus afternoon exercise on acute responses in phosphorylation of proteins regulating muscle size and metabolism. Twenty-two untrained men, divided into the morning (n = 11) or afternoon (n = 11) group, performed maximal isometric leg extensions before and after resistance loading at 07:30–08:30 h and 16:00–17:00 h, respectively. Muscle pre- and postloading biopsies were analyzed for phosphorylated Akt, p70S6K, rpS6, p38 mitogen-activated protein kinase (MAPK), Erk1/2, and eukaryotic elongation factor (eEF) 2. Muscle force declined after exercise in both groups (p < 0.001). p70S6K Thr389 (p < 0.05) and Thr421/Ser424 and rpS6 (all p < 0.001) increas…

medicine.medical_specialtyAnabolismPhysiologybusiness.industryInsulinmedicine.medical_treatmentSkeletal muscleIsometric exerciseEEF2medicine.anatomical_structureEndocrinologyPhysiology (medical)Internal medicineVDP::Matematikk og Naturvitenskap: 400::Basale biofag: 470medicinePhosphorylationta315businessProtein kinase BEcology Evolution Behavior and SystematicsMorningBiological Rhythm Research
researchProduct

AT1 Receptor Gene Polymorphisms in relation to Postprandial Lipemia

2011

Background. Recent data suggest that the renin-angiotensin system may be involved in triglyceride (TG) metabolism. We explored the effect of the common A1166C and C573T polymorphisms of the angiotensin II type 1 receptor (AT1R) gene on postprandial lipemia.Methods. Eighty-two subjects measured daytime capillary TG, and postprandial lipemia was estimated as incremental area under the TG curve. The C573T and A1166C polymorphisms of the AT1R gene were determined.Results. Postprandial lipemia was significantly higher in homozygous carriers of the 1166-C allele (9.39±8.36 mM*h/L) compared to homozygous carriers of the 1166-A allele (2.02±6.20 mM*h/L) (P&lt;0.05). Postprandial lipemia was similar…

medicine.medical_specialtyAngiotensin II receptor type 1Article SubjectTriglyceridebusiness.industrydigestive oral and skin physiologyMetabolismAngiotensin IIchemistry.chemical_compoundPostprandialEndocrinologychemistryRC666-701Internal medicineClinical StudyDiseases of the circulatory (Cardiovascular) systemMedicineAlleleCardiology and Cardiovascular MedicinebusinessReceptorGene
researchProduct

Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study

2020

Altres ajuts: This work was supported in part by Fundació La Marató de TV3 (201516-10, 201502-30), Societat Catalana de Cardiologia, "la Caixa" Banking Foundation. Altres ajuts: PERIS/SLT002-16-00234 Sacubitril/valsartan is a first-in-class angiotensin receptor-neprilysin inhibitor developed for the treatment of heart failure with reduced ejection fraction. Its benefits are achieved through the inhibition of neprilysin (NEP) and the specific blockade of the angiotensin receptor AT1. The many peptides metabolized by NEP suggest multifaceted potential consequences of its inhibition. We sought to evaluate the short-term changes in serum endorphin (EP) values and their relation with patients' p…

medicine.medical_specialtyAngiotensin receptorEndorphins; Heart failure; Neprilysin; Sacubitril/valsartan; α-Endorphin; γ-Endorphinα‐EndorphinVascular damage Radboud Institute for Health Sciences [Radboudumc 16]HemodynamicsPilot ProjectsHeart failure030204 cardiovascular system & hematologyγ‐EndorphinvalsartanSacubitril03 medical and health sciences0302 clinical medicineOriginal Research ArticlesInternal medicinemedicineHumansDiseases of the circulatory (Cardiovascular) systemalpha-EndorphinOriginal Research ArticleProspective Studies030212 general & internal medicineSacubitril/valsartanγ-EndorphinAngiotensin II receptor type 1Ejection fractionbusiness.industryα-EndorphinStroke Volumegamma-Endorphinmedicine.diseaseSacubitrilValsartanRC666-701Heart failureCardiologyNeprilysinEndorphinsCardiology and Cardiovascular MedicinebusinessSacubitril Valsartanmedicine.drug
researchProduct

Anthropometric and physical characteristics allow differentiation of young female volleyball players according to playing position and level of exper…

2017

The aim of our study was to determine the differences in some anthropometric and physical performance variables of young Croatian female volleyball players (aged 13 to 15) in relation to playing position (i.e., independent variable) and performance level within each position (i.e., independent variable). Players were categorized according to playing position (i.e., role) as middle blockers (n=28), opposite hitters (n=41), passer-hitters (n=54), setters (n=30), and liberos (n=28). Within each position, players were divided into a more successful group and a less successful group according to team ranking in the latest regional championship and player quality within the team. Height and body …

medicine.medical_specialtyAnthropometry Motor activity Analysis of variancemedia_common.quotation_subjectanalysis of variance; anthropometry; motor activityPhysical Therapy Sports Therapy and RehabilitationMotor activity03 medical and health sciences0302 clinical medicinePhysiology (medical)medicine0601 history and archaeologyOrthopedics and Sports MedicineMass indexlcsh:Sports medicineChampionshipAnalysis of varianceYoung femalelcsh:QH301-705.5media_commonOriginal Paper060101 anthropologyVariablesAnthropometryUpper body030229 sport sciences06 humanities and the artsAnthropometryAnalysis of variance.Position (obstetrics)lcsh:Biology (General)Physical therapylcsh:RC1200-1245PsychologySettore M-EDF/01 - Metodi E Didattiche Delle Attivita' MotorieBody mass indexAnalysis of variance Anthropometry Motor activityDemographyBiology of Sport
researchProduct

Can supplementation with vitamin C and E alter physiological adaptations to strength training?

2014

Published version of an article from the journal: BMC Sports Science, Medicine and Rehabilitation. Also available from the publisher: http://dx.doi.org/10.1186/2052-1847-6-28 Background: Antioxidant supplementation has recently been demonstrated to be a double-edged sword, because small to moderate doses of exogenous antioxidants are essential or beneficial, while high doses may have adverse effects. The adverse effects can be manifested in attenuated effects of exercise and training, as the antioxidants may shut down some redox-sensitive signaling in the exercised muscle fibers. However, conditions such as age may potentially modulate the need for antioxidant intake. Therefore, this paper …

medicine.medical_specialtyAntioxidantDoseSports medicineStrength trainingmedicine.medical_treatmentPhysiologyPhysical Therapy Sports Therapy and RehabilitationPlacebo1 repetition maximumlaw.inventionStudy ProtocolRandomized controlled triallawmedicineOrthopedics and Sports MedicineAdverse effectVitamin Cbusiness.industryRehabilitationprotocol paperantioxidantsmuscle massPhysical therapymuscle strengthVDP::Medical disciplines: 700::Sports medicine: 850business
researchProduct

Biochemical adaptations in middle-distance runners: an assessment of blood and anthropometric parameters

2014

In order to understand the mechanism underlying the physiological adaptation of purely aerobic workout, we investigated the effect of 2 months of training on nine males (17-22 year-old) middle distance running agonistic athletes. Blood sample was collected in the morning to analyze: hematological parameters, lipid profile, liver function enzymes [glutamate oxaloacetate transaminase, glutamate pyruvate transaminase, gamma-glutamyl transferase (γ-GT)] and skeletal and myocardial markers of muscle damage [creatin kinase (CK) and creatin kinase MB (CK-MB)]. Endurance training, as it implies high oxygen consumption, should increase reactive oxygen species, but it has been shown that exercise lea…

medicine.medical_specialtyAntioxidantmedicine.medical_treatmentPlant ScienceOxidative phosphorylationBiologymedicine.disease_causeSettore BIO/09 - FisiologiaGeneral Biochemistry Genetics and Molecular BiologyEndurance trainingInternal medicineSettore BIO/10 - BiochimicamedicineAerobic exerciselcsh:QH301-705.5MorningSettore M-EDF/02 - Metodi E Didattiche Delle Attivita' Sportivemedicine.diagnostic_testBiochemistry (medical)Endocrinologylcsh:Biology (General)BiochemistryLiver functionmiddle-distance runners oxidative stress CK-MB biochemical parameters body weightLipid profileSettore M-EDF/01 - Metodi E Didattiche Delle Attivita' MotorieOxidative stress
researchProduct

Complémentarité et équilibre de l’apport alimentaire en protéines et en lipides

2003

The nature and level of dietary protein is liable to influence cholesterol and essential fatty acid (EFA) metabolism. Dietary vegetable protein, particularly the undigested fraction, decreases intestinal cholesterol absorption, increases the faecal excretion of steroids, and enhances the catabolism of cholesterol-carrying lipoproteins by increasing the activity or number of LDL receptors. However, the hypocholesterolemic effect of protein may be due to the presence of non-protein components and hence the purity degree of the selected protein, and the concomitant addition or not of cholesterol. Dietary proteins with different amino acid composition may modulate the secretion of hormones (e.g…

medicine.medical_specialtyAntioxidantmedicine.medical_treatmentlcsh:TP670-699soy proteinBiochemistrycaseinchemistry.chemical_compoundEssential fatty acidInternal medicinemedicineessential fatty acidchemistry.chemical_classificationCatabolismChemistryCholesterolcholesterolMetabolismprotein malnutritionperoxidationEndocrinologyLDL receptorIntestinal cholesterol absorptionlipids (amino acids peptides and proteins)lcsh:Oils fats and waxesFood SciencePolyunsaturated fatty acidOléagineux, Corps gras, Lipides
researchProduct

Quantitative and qualitative effects of rosuvastatin on LDL-cholesterol: what is the clinical significance ?

2009

Summary Background:  Statins have emerged as the global leader in pharmacologic therapy for dyslipidaemia, and rosuvastatin has demonstrated clinical efficacy as well as safety in several clinical trials and postmarketing analyses. Aim:  The present article reviewed the effects of rosuvastatin on the quantity and the quality of low-density lipoproteins (LDL). Methods:  We searched for and reviewed all the available evidence in a systematic way. A literature search (by Medline and Scopus) was performed using the following headings: ‘LDL-cholesterol’, ‘LDL size’, ‘LDL subclasses’, ‘small dense LDL’, ‘apolipoprotein B, apo B’ and ‘rosuvastatin’ up to 11 November 2008. The authors also manually…

medicine.medical_specialtyApolipoprotein BHypercholesterolemia10265 Clinic for Endocrinology and DiabetologyMEDLINE610 Medicine & health2700 General MedicinePharmacotherapyInternal medicineDiabetes mellitusmedicineHumansLDL-cholesterolRosuvastatinClinical significanceRosuvastatin CalciumAgedClinical Trials as TopicSulfonamidesbiologybusiness.industrynutritional and metabolic diseasesCholesterol LDLGeneral Medicinemedicine.diseaseFluorobenzenesPrimary PreventionClinical trialPyrimidinesTreatment OutcomeEndocrinologyCardiovascular Diseasesrosuvastatin LDL-cholesterol type-2 diabetesHMG-CoA reductasebiology.proteinlipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase Inhibitorsbusinessmedicine.drug
researchProduct

Physiological and Nutritional Roles of PPAR across Species.

2013

There has been a tremendous amount of information produced on peroxisome proliferator-activated receptors (PPARs). The interest in PPARs was originally driven largely by their role in hypolipidemia and hepatocarcinogenesis, but it soon became evident that they played important roles in the metabolic syndrome and overall health of organisms including regeneration of tissues, differentiation, insulin signaling, overall lipid metabolism, and immune response (reviewed in [1–7]). From a nutritional standpoint, the PPARs are of extreme importance because of their ability to bind and be activated by long-chain fatty acids and their metabolites. Therefore, the PPARs are recognized as ideal candidat…

medicine.medical_specialtyArticle SubjectAnimal food[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Peroxisome proliferator-activated receptorAdipose tissueContext (language use)White adipose tissueBiologyBioinformaticsEnergy homeostasis03 medical and health sciencesInternal medicineDrug Discoverymedicine[SDV.BBM] Life Sciences [q-bio]/Biochemistry Molecular Biology[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Pharmacology (medical)[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular Biologylcsh:QH301-705.5[ SDV.BBM ] Life Sciences [q-bio]/Biochemistry Molecular BiologyComputingMilieux_MISCELLANEOUS030304 developmental biology2. Zero hungerchemistry.chemical_classification[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism0303 health sciences[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]0402 animal and dairy scienceLipid metabolism04 agricultural and veterinary sciences[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism[ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism040201 dairy & animal scienceNutrigenomicsEndocrinologyEditoriallcsh:Biology (General)chemistry
researchProduct

PPAR in Cardiovascular Disorders

2016

Peroxisome proliferation-activated receptors (PPARs) are ligand-inducible transcription factors that, upon binding their ligands, translocate into the nucleus, where they regulate transcription of numerous genes that have the peroxisome proliferator response element (PPRE) in the promoter region [1]. In humans, there are 3 PPAR isoforms: PPAR-α, PPAR-β/δ, and PPAR-γ. The isoforms have partially overlapping spectra of activity and are differently expressed in organs and tissues [2]. PPAR-α is expressed mostly in tissues characterized by high catabolic activity, including skeletal muscle, liver, proximal tubular cells in kidneys, and brown fat. This PPAR isoform regulates components of β-oxid…

medicine.medical_specialtyArticle SubjectPeroxisome proliferator-activated receptor030209 endocrinology & metabolism030204 cardiovascular system & hematologyBiology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDownregulation and upregulationInternal medicineDrug DiscoverymedicineGlucose homeostasisPharmacology (medical)Beta oxidationlcsh:QH301-705.5chemistry.chemical_classificationFatty acid metabolismLipid metabolismPeroxisomeEndocrinologyEditorialchemistrylcsh:Biology (General)Rosiglitazonemedicine.drugPPAR Research
researchProduct